PETER R CULPEPPER Insider Trading $PVCT PROVECTUS BIOPHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER R CULPEPPER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER R CULPEPPER. PETER R CULPEPPER is CFO & COO in PROVECTUS BIOPHARMACEUTICALS, INC. ($PVCT) and Chief Financial Officer in PROVECTUS BIOPHARMACEUTICALS, INC. ($PVCT) and Interim CEO, CFO, COO in PROVECTUS BIOPHARMACEUTICALS, INC. ($PVCT).
PETER R CULPEPPER in PROVECTUS BIOPHARMACEUTICALS, INC.
Trading Symbol: PVCTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER R CULPEPPER: Interim CEO, CFO, COO, CFO & COO, Chief Financial Officer
Holdings: 296,503 shares
Current Value: $5,930
Latest Transaction: Mar 31 2016
$PVCT Market Capitalization: $4.61M
$PVCT Previous Close: $0.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PETER R CULPEPPER in PROVECTUS BIOPHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 0.85 | 133,333 | 113,333 | 133,333 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 1.00 | 133,333 | 133,333 | 0 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 0.85 | 133,333 | 113,333 | 133,333 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Option Exercise | O | 1.00 | 133,333 | 133,333 | 0 | |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 106,000 | 106,000 | 296,503 | 190.5 K to 296.5 K (+55.64 %) |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 27,333 | 27,333 | 1,411,829 | 1.4 M to 1.4 M (+1.97 %) |
Mar 31 2016 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Interim CEO, CFO, C ... | Buy | O | 1.00 | 133,333 | 133,333 | 1,384,496 | 1.3 M to 1.4 M (+10.66 %) |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Option Exercise | M | 0.94 | 145,214 | 136,501 | 0 | |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Option Exercise | A | 0.75 | 400,000 | 300,000 | 400,000 | |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Buy | M | 0.94 | 6,383 | 6,000 | 190,503 | 184.1 K to 190.5 K (+3.47 %) |
Dec 10 2015 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | CFO & COO | Buy | M | 0.94 | 138,831 | 130,501 | 1,251,163 | 1.1 M to 1.3 M (+12.48 %) |
Jun 26 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | A | 1.02 | 1,000,000 | 1,020,000 | 1,000,000 | |
Jun 01 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,500 | 3,850 | 255,419 | |
Jun 01 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,666 | 4,033 | 258,919 | |
Jun 01 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,500 | 3,850 | 44,581 | 41.1 K to 44.6 K (+8.52 %) |
Jun 01 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,666 | 4,033 | 41,081 | 37.4 K to 41.1 K (+9.80 %) |
Jan 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,499 | 3,849 | 269,985 | |
Jan 31 2006 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,499 | 3,849 | 30,015 | 26.5 K to 30 K (+13.20 %) |
Dec 01 2005 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,788 | 4,167 | 277,272 | |
Dec 01 2005 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,788 | 4,167 | 22,728 | 18.9 K to 22.7 K (+20.00 %) |
Nov 07 2005 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,788 | 4,167 | 281,060 | |
Nov 07 2005 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,788 | 4,167 | 18,940 | 15.2 K to 18.9 K (+25.00 %) |
Oct 03 2005 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 3,788 | 4,167 | 284,848 | |
Oct 03 2005 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 3,788 | 4,167 | 15,152 | 11.4 K to 15.2 K (+33.33 %) |
Aug 31 2005 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | M | 1.10 | 11,364 | 12,500 | 288,636 | |
Aug 31 2005 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Buy | M | 1.10 | 11,364 | 12,500 | 11,364 | 0 to 11.4 K |
May 26 2005 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | A | 0.58 | 300,000 | 174,000 | 300,000 | |
Jul 07 2004 | PVCT | PROVECTUS BIOPHARM ... | CULPEPPER PETER R | Chief Financial Off ... | Option Exercise | A | 1.25 | 100,000 | 125,000 | 100,000 |
Page: 1